Literature DB >> 3063805

Central nervous system dysfunction in acquired immunodeficiency syndrome.

R M Levy1, D E Bredesen.   

Abstract

Nearly 40% of AIDS patients develop neurological complications during the course of their illness, and about 10% experience neurological symptoms as the initial manifestations of AIDS. The most common neurological complication (14% of AIDS patients) is human immunodeficiency virus (HIV) encephalopathy, but opportunistic viral and nonviral infections and neoplasms are also quite common; the most frequent among these are cryptococcal meningitis, toxoplasmosis, primary central nervous system (CNS) lymphoma, progressive multifocal leukoencephalopathy, and herpesvirus infections. Most of the nonviral infections and neoplasms are potentially treatable. Neurological syndromes include diffuse and regional encephalopathies, myelopathy, meningitis, intraaxial cranial neuropathies, and retinopathy. About 10% of AIDS patients develop a CNS mass lesion; the chief causes of these lesions are toxoplasmosis and primary CNS lymphoma. Since the clinical profiles of the various diseases overlap to a great extent, differential diagnosis requires a thorough workup, including magnetic resonance imaging or computed tomography brain scanning, examination of the cerebrospinal fluid, and, frequently, brain biopsy. Because AIDS patients have a high incidence of multiple intracranial pathologies, the diagnostic workup may have to be repeated to identify all of the diseases present.

Entities:  

Mesh:

Year:  1988        PMID: 3063805

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  22 in total

1.  Laboratory techniques in the investigation of fungal infections.

Authors:  R J Hay
Journal:  Genitourin Med       Date:  1992-12

2.  Primary T-cell lymphoma of the brain in acquired immunodeficiency syndrome: case report.

Authors:  A K Bindal; K S Blisard; H Melin-Aldama; R E Warnick
Journal:  J Neurooncol       Date:  1997-02       Impact factor: 4.130

3.  Antifungal properties of essential oils and their main components upon Cryptococcus neoformans.

Authors:  C Viollon; J P Chaumont
Journal:  Mycopathologia       Date:  1994-12       Impact factor: 2.574

4.  Ocular toxoplasmosis in AIDS patients.

Authors:  D J Gagliuso; S A Teich; A H Friedman; J Orellana
Journal:  Trans Am Ophthalmol Soc       Date:  1990

5.  Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies.

Authors:  David F Tate; Mehul Sampat; Jaroslaw Harezlak; Mark Fiecas; Joseph Hogan; Jeffrey Dewey; Daniel McCaffrey; Daniel Branson; Troy Russell; Jared Conley; Michael Taylor; Giovanni Schifitto; Giavoni Schifitto; J Zhong; Eric S Daar; Jeffrey Alger; Mark Brown; Elyse Singer; T Campbell; D McMahon; Y Tso; Janetta Matesan; Scott Letendre; S Paulose; Michelle Gaugh; C Tripoli; Constantine Yiannoutsos; Erin D Bigler; Ronald A Cohen; Charles R G Guttmann; Bradford Navia
Journal:  J Neurovirol       Date:  2011-05-10       Impact factor: 2.643

6.  Recent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients.

Authors:  David F Tate; Allison Delong; Daniel E McCaffrey; Kinga Kertesz; Robert H Paul; Jared Conley; Troy Russell; Kathleen Coop; Fizza Gillani; Timothy Flanigan; Karen Tashima; Joseph W Hogan
Journal:  Arch Clin Neuropsychol       Date:  2011-08-25       Impact factor: 2.813

Review 7.  Review of antiretroviral therapy in the prevention of HIV-related AIDS dementia complex (ADC).

Authors:  P Portegies
Journal:  Drugs       Date:  1995       Impact factor: 9.546

8.  Cerebrospinal fluid cytokines in AIDS dementia complex.

Authors:  O Perrella; P B Carrieri; D Guarnaccia; M Soscia
Journal:  J Neurol       Date:  1992-08       Impact factor: 4.849

9.  Early pathological changes in progressive multifocal leukoencephalopathy: a report of two asymptomatic cases occurring prior to the AIDS epidemic.

Authors:  K E Aström; G L Stoner
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Immunoglobulin G subclass preference of intrathecally produced HIV-specific oligoclonal antibodies.

Authors:  R Kaiser; R Dörries; B Ruf; H D Pohle; R Martin; V ter Meulen
Journal:  J Neurol       Date:  1991-09       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.